Fibroblast growth factor-23 and Alpha-Klotho concentrations in dogs with canine Leishmaniasis.

Abstract

This study aimed to assess the concentrations of Fibroblast Growth Factor-23 (FGF-23) and &#x3b1;-Klotho in healthy dogs and dogs at different stages of Canine Leishmaniasis (CanL), and investigate the changes of these parameters in relation to renal function and calcium&#x2011;phosphorus metabolism. A total of 74 dogs (22 healthy and 52 with CanL) of varying ages, sexes, and medium-sized breeds were included. Dogs with CanL were categorized into different stages (Stage I-IV) based on Leishvet recommendations. In addition to routine hematological parameters, plasma FGF-23, serum &#x3b1;-Klotho, urea, creatinine, phosphorus, calcium, parathormone, vitamin D concentrations, and urine protein/creatinine ratio were measured. Data from healthy dogs were compared to dogs with CanL overall and by stage. Dogs with CanL exhibited higher concentrations of FGF-23 (p&#xa0;<&#xa0;0.05), &#x3b1;-Klotho, and parathormone (p&#xa0;<&#xa0;0.001), as well as lower concentrations of vitamin D and calcium (p&#xa0;<&#xa0;0.001). FGF-23 concentration was particularly elevated in Stage IV compared to other stages. However, no significant differences in &#x3b1;-Klotho levels were observed among the stages. FGF-23 levels showed a weak positive correlation with urea and creatinine concentrations and a moderate positive correlation with urine protein/creatinine ratio. This study demonstrated increased levels of FGF-23 and &#x3b1;-Klotho in dogs with CanL for the first time. The increase in FGF-23 levels was more prominent in advanced stages of the disease and correlated with higher urea and creatinine concentrations. These findings may serve as a basis for future diagnostic and therapeutic investigations, contributing to the understanding of the pathophysiology of kidney disease in CanL.